XETRA - Delayed Quote EUR

Qiagen N.V. (QIA.DE)

37.61

+0.07

+(0.17%)

At close: 5:40:41 PM GMT+2

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

VENLO, Netherlands, April 22, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a series of product and partnership updates designed to strengthen its portfolio for cancer genomic profiling.

Business Wire 2 days ago

QGEN
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation?

Key Insights The projected fair value for Qiagen is US$60.71 based on 2 Stage Free Cash Flow to Equity Qiagen is...

Simply Wall St. 2 days ago

QGEN
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks 8 days ago

QGEN
Qiagen Plans 3 New Sample Preparation Instrument Launches Through 2026

Qiagen (QGEN) said Tuesday it plans to launch three new sample preparation instruments, QIAsymphony

PREMIUM
MT Newswires 9 days ago

QGEN
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation

VENLO, Netherlands, April 15, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that plans are advancing to launch three new sample preparation instruments during 2025 and 2026 to expand and strengthen its portfolio for automated sample preparation.

Business Wire 9 days ago

QGEN
Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?

Biogen (BIIB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks 14 days ago

BIIB

QGEN
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast

VENLO, The Netherlands, April 08, 2025--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2025.

Business Wire 16 days ago

QGEN
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook

VENLO, Netherlands, April 06, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary Q1 2025 results that exceeded its outlook for both net sales and adjusted earnings per share (EPS), reflecting strong performances across many growth drivers.

Business Wire 18 days ago

QGEN
Qiagen Full Year 2024 Earnings: EPS Misses Expectations

Qiagen ( NYSE:QGEN ) Full Year 2024 Results Key Financial Results Revenue: US$1.98b (flat on FY 2023). Net income...

Simply Wall St. 22 days ago

QGEN
QIAGEN Launches QIAprep&amp Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts

VENLO, Netherlands, April 01, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts.

Business Wire 23 days ago

QGEN
Bio-Techne Opens New Customer Experience Centre in Germany

TECH announces the opening of a new Customer Experience Centre to support long-term growth in the EMEA region. The new facility is located in Dusseldorf, Germany.

Zacks 24 days ago

TECH

QGEN

BIO-B
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results

VENLO, Netherlands, March 31, 2025--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission. The document can be accessed on QIAGEN’s website here.

Business Wire 24 days ago

QGEN
Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Qiagen (NYSE:QGEN) has had a rough three months with its share price down 14%. It seems that the market might have...

Simply Wall St. 27 days ago

QGEN
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now?

QGEN's robust expansion of its testing menu and potential in molecular diagnostics bode well for investors.

Zacks last month

QGEN
The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses

For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...

Simply Wall St. last month

QGEN
Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

QGEN

AMGN
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B

This clearance represents the company’s second FDA clearance for a QIAstat-Dx panel this year.

Medical Device Network last month

QGEN
QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel

QIAGEN wins the FDA's clearance for the second QIAstat-Dx mini gastrointestinal panel.

Zacks last month

QGEN
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

GERMANTOWN, Md. & VENLO, Netherlands, March 06, 2025--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, further strengthening its syndromic testing portfolio in the United States.

Business Wire last month

QGEN
Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now

We recently compiled a list of the 10 Cash-Rich Mid Cap Stocks To Buy Now. In this article, we are going to take a look at where Qiagen N.V. (NYSE:QGEN) stands against the other cash-rich mid cap stocks. Cash flow is the money moving in and out of a business over a set period. It is […]

Insider Monkey last month

QGEN

Performance Overview

Return	QIA.DE	S&P 500 (^GSPC)
YTD	-15.05%	-6.75%
1-Year	-5.21%	+8.15%
3-Year	-15.63%	+28.40%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Qiagen N.V. (QIA.DE)

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation?

Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term

Qiagen Plans 3 New Sample Preparation Instrument Launches Through 2026

QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation

Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?

QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast

QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook

Qiagen Full Year 2024 Earnings: EPS Misses Expectations

QIAGEN Launches QIAprep&amp Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts

Bio-Techne Opens New Customer Experience Centre in Germany

QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results

Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Is it Worth Retaining QIAGEN Stock in Your Portfolio Now?

The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B

QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now

Performance Overview